Kevin Paul Baker serves as Executive at FIVE PRIME THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Kevin Paul Baker has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 26, 2018 involved receiving (via award) 3,500 shares valued at $0.
Kevin Paul Baker currently holds 78,184 shares of FIVE PRIME THERAPEUTICS INC (FPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Paul Baker has been a net neutral trader of FPRX stock. They have purchased $0 and sold $0 worth of shares.
Kevin Paul Baker's most recent insider trade was on Feb 26, 2018, when they sold 3,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $18.42 |
| Discretionary |
| Feb 1, 2018 | FPRX | $372.2K | Payment | 18,866 | $19.73 | Discretionary |
| Sep 1, 2017 | FPRX | $32.3K | Payment | 940 | $34.34 | Discretionary |
| Aug 25, 2016 | FPRX | $0 | Award | 7,500 | $N/A | Discretionary |
| Feb 1, 2016 | FPRX | $0 | Award | 75,000 | $N/A | Discretionary |